Inventor · disambiguated record
Masaki Terabe
Also filed as: TERABE MASAKI
8 granted patents·5 pending applications·17 citations·filing 2003–2025
79Inventor score
Files withUS HEALTH5BERZOFSKY JAY A3GOVERNMENT OF THE US AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES1TERABE MASAKI1THE US SECRETARY DEPT OF HEALTH AND HUMAM SERVICES1
Top patents by PatentIndex Score
13 records- 0187US8835613B2β-mannosylceramide and stimulation of NKT cell anti-tumor immunityBERZOFSKY JAY A·Filed 2011·Granted Sep 16, 2014·13 cites·24 claims
- 0270US9168291B2β-mannosylceramide and stimulation of NKT cell anti-tumor immunityUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICE·Filed 2014·Granted Oct 27, 2015·2 cites·22 claims
- 0368US10286050B2Multi-epitope TARP peptide vaccine and uses thereofUS HEALTH·Filed 2014·Granted May 14, 2019·2 cites·14 claims
- 0466US9394352B2Immunogenic POTE peptides and methods of useUS HEALTH·Filed 2014·Granted Jul 19, 2016·0 cites·18 claims
- 0564US2025222016A13-o-sulfo-galactosylceramide analogs as activators of type ii nkt cells and uses thereofUS HEALTH·Filed 2025·Application pending·0 cites
- 0660US12268700B23-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereofUS HEALTH·Filed 2019·Granted Apr 8, 2025·0 cites·5 claims
- 0756US8871902B2Immunogenic POTE peptides and methods of useBERZOFSKY JAY A·Filed 2012·Granted Oct 28, 2014·0 cites·31 claims
- 0851US11266726B2Compositions and methods for the treatment of HER2-expressing solid tumorsUS HEALTH·Filed 2016·Granted Mar 8, 2022·0 cites·14 claims
- 0951US2008267964A1Synergistic Effect of Tgf-Beta Blockade and Immunogenic Agents on TumorsTERABE MASAKI·Filed 2006·Application pending·0 cites
- 1046US2013171178A1Immunogenic Peptides of Xage-1BERZOFSKY JAY A·Filed 2004·Application pending·0 cites
- 1144US9517243B2Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunityTHE US SECRETARY DEPT OF HEALTH AND HUMAM SERVICES·Filed 2015·Granted Dec 13, 2016·0 cites·16 claims
- 1244US2011268749A1Treatment of cancer via targeting of il-13 receptor-alpha2GOVERNMENT OF THE US AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2008·Application pending·0 cites
- 1343US2006057145A1Methods to prevent tumor recurrence by blockade of tgf-betaUS GOV HEALTH & HUMAN SERV·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →